These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 19184655)

  • 21. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.
    D'Souza MS; Markou A
    Addict Sci Clin Pract; 2011 Jul; 6(1):4-16. PubMed ID: 22003417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rodent models for nicotine withdrawal.
    Chellian R; Behnood-Rod A; Bruijnzeel DM; Wilson R; Pandy V; Bruijnzeel AW
    J Psychopharmacol; 2021 Oct; 35(10):1169-1187. PubMed ID: 33888006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
    Biala G; Staniak N; Budzynska B
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Apr; 381(4):361-70. PubMed ID: 20217050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice.
    Damaj MI; Grabus SD; Navarro HA; Vann RE; Warner JA; King LS; Wiley JL; Blough BE; Lukas RJ; Carroll FI
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1087-95. PubMed ID: 20576796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic background influences the effects of withdrawal from chronic nicotine on learning and high-affinity nicotinic acetylcholine receptor binding in the dorsal and ventral hippocampus.
    Wilkinson DS; Turner JR; Blendy JA; Gould TJ
    Psychopharmacology (Berl); 2013 Jan; 225(1):201-8. PubMed ID: 22836371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Galantamine attenuates some of the subjective effects of intravenous nicotine and improves performance on a Go No-Go task in abstinent cigarette smokers: a preliminary report.
    Sofuoglu M; Herman AI; Li Y; Waters AJ
    Psychopharmacology (Berl); 2012 Dec; 224(3):413-20. PubMed ID: 22700039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.
    Costello MR; Reynaga DD; Mojica CY; Zaveri NT; Belluzzi JD; Leslie FM
    Neuropsychopharmacology; 2014 Jul; 39(8):1843-51. PubMed ID: 24513971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of dopamine in the behavioural actions of nicotine related to addiction.
    Di Chiara G
    Eur J Pharmacol; 2000 Mar; 393(1-3):295-314. PubMed ID: 10771025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of nicotine in smoking: a dual-reinforcement model.
    Caggiula AR; Donny EC; Palmatier MI; Liu X; Chaudhri N; Sved AF
    Nebr Symp Motiv; 2009; 55():91-109. PubMed ID: 19013940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a nonhuman model of contingency management: effects of reinforcing abstinence from nicotine self-administration in rats with an alternative nondrug reinforcer.
    Lesage MG
    Psychopharmacology (Berl); 2009 Mar; 203(1):13-22. PubMed ID: 18946663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the cannabinoid system in nicotine addiction.
    Castañé A; Berrendero F; Maldonado R
    Pharmacol Biochem Behav; 2005 Jun; 81(2):381-6. PubMed ID: 15925402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the interoceptive stimulus effects of nicotine and varenicline.
    Thompson BM; Barrett ST; Bevins RA
    Pharmacol Biochem Behav; 2019 Jun; 181():9-16. PubMed ID: 30954637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine.
    Grieder TE; Sellings LH; Vargas-Perez H; Ting-A-Kee R; Siu EC; Tyndale RF; van der Kooy D
    Neuropsychopharmacology; 2010 Mar; 35(4):943-54. PubMed ID: 20032966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Age-dependent differences in nicotine reward and withdrawal in female mice.
    Kota D; Martin BR; Damaj MI
    Psychopharmacology (Berl); 2008 Jun; 198(2):201-10. PubMed ID: 18338157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tobacco particulate matter self-administration in rats: differential effects of tobacco type.
    Brennan KA; Crowther A; Putt F; Roper V; Waterhouse U; Truman P
    Addict Biol; 2015 Mar; 20(2):227-35. PubMed ID: 24750334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice.
    Hilario MR; Turner JR; Blendy JA
    Neuropsychopharmacology; 2012 Nov; 37(12):2661-70. PubMed ID: 22828747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discriminative stimulus effects of nicotine in humans.
    Perkins KA
    Handb Exp Pharmacol; 2009; (192):369-400. PubMed ID: 19184656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Reinforcing Effects of Nicotine in Humans and Nonhuman Primates: A Review of Intravenous Self-Administration Evidence and Future Directions for Research.
    Goodwin AK; Hiranita T; Paule MG
    Nicotine Tob Res; 2015 Nov; 17(11):1297-310. PubMed ID: 25673111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactive effects of ethanol and nicotine on learning in C57BL/6J mice depend on both dose and duration of treatment.
    Gulick D; Gould TJ
    Psychopharmacology (Berl); 2008 Feb; 196(3):483-95. PubMed ID: 17968532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in mechanisms underlying reinstatement of cigarette smoke extract- and nicotine-seeking behavior in rats.
    Cross SJ; Reynaga DD; Cano M; Belluzzi JD; Zaveri NT; Leslie FM
    Neuropharmacology; 2020 Jan; 162():107846. PubMed ID: 31704271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.